Wilt TJ (ed.)
In mouse models of insulin resistance, it significantly inhibits NNMT activity in liver and muscle, reduces NAM methylation, increases intracellular NAD+, activates the SIRT1 pathway, promotes phosphorylation of insulin receptor substrate 1 (IRS1), enhances insulin signaling, improves insulin sensitivity, and increases glucose uptake and utilization
Pancragen (Lys-Glu-Asp-Trp, KEDW) is included in the comparison below as the third member of the digestive-system group these two are usually cross-shopped against
A 2001 editorial in the European Journal of Anaesthesiology described DSIP as "incredibly safe," noting that no dose had ever killed an animal subject in research, and the only human side effects observed were transient headache, nausea, and vertigo
Read the interview below to get to know her.